Serum proteomic profiling of advanced gastric cancer and identification of proteomic changes following response to epirubicin, cisplatin and capecitabine chemotherapy as diagnostic and predictive biomarkers

Helgi H. Helgason,Judith Y. M. N. Engwegen,Annemieke Cats,Henk Boot,Maria Kuiper,Marc Zapatka,Markus Joerger,Jos H. Beijnen,Jan H. M. Schellens

Serum proteomic profiling of advanced gastric cancer and identification of proteomic changes following response to epirubicin, cisplatin and capecitabine chemotherapy as diagnostic and predictive biomarkers

2007

Helgi H. Helgason
Judith Y. M. N. Engwegen
Annemieke Cats
Henk Boot
Maria Kuiper
Marc Zapatka
Markus Joerger
Jos H. Beijnen
Jan H. M. Schellens

4537 Background: Gastric cancer is the fourth most commonly diagnosed cancer and is the second leading cause of cancer death worldwide. Prognosis is highly dependent on stage at diagnosis making ea...

Keywords:

Capecitabine
Cancer
Cisplatin
Epirubicin
Oncology
Proteomic Profiling
Chemotherapy
Internal medicine
Biomarker (medicine)
Medicine
predictive biomarker
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations